Ekaterina Bordea

9PUBLICATIONS
91CO-AUTHORS
Gene and molecular therapyHaematological tumoursCardiology (incl. cardiovascular diseases)OrthopticsMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 29, 2026
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.

|Apr 01, 2026
Early Versus Delayed Anticoagulation in Acute Ischemic Stroke According to Atrial Fibrillation Subtype and Time of Diagnosis: Subgroup Analysis of the OPTIMAS Randomized Controlled Trial.

James Lyon, Philip S Nash, Norin Ahmed

|Mar 30, 2026
Early versus delayed anticoagulation in acute ischemic stroke with atrial fibrillation according to infarct volume and location: A prespecified subgroup analysis of the OPTIMAS randomized controlled trial.

Philip S Nash, Jonathan Best, James Lyon

|May 22, 2025
Anticoagulation Timing in Acute Stroke With Atrial Fibrillation According to Chronic Kidney Disease: The OPTIMAS Trial.

Philip S Nash, Hakim-Moulay Dehbi, Norin Ahmed

|Jan 08, 2024
Cost-Utility Analysis of Total Ankle Replacement Compared with Ankle Arthrodesis for Patients Aged 50-85 Years with End-Stage Ankle Osteoarthritis: The TARVA Study.

Andrew J Goldberg, Ekaterina Bordea, Kashfia Chowdhury

|Apr 06, 2023
Total ankle replacement versus ankle arthrodesis for patients aged 50-85 years with end-stage ankle osteoarthritis: the TARVA RCT.

Andrew J Goldberg, Kashfia Chowdhury, Ekaterina Bordea

Pageof 2

Frequent Collaborators

5 joint publications

Caroline J Doré

3 joint publications

Stefan T Engelter

3 joint publications

Macey Lee Murray

3 joint publications

James Blackstone